Prof. Katayun Barmak was a featured speaker at the Women in Engineering Day on April 19, hosted by Columbia Engineering’s undergraduate chapter of the Society of Women Engineers (SWE). The event, hosted by Dean Mary Boyce, featured 5 faculty members who spoke about their current research and also offered advice and insights from their career paths.
The grand challenge to improve energy storage and increase battery life, while ensuring safe operation, is becoming evermore critical as we become increasingly reliant on this energy source for everything from portable devices to electric vehicles. A Columbia Engineering team led by Yuan Yang, assistant professor of materials science and engineering, announced today that they have developed a new method for safely prolonging battery life by inserting a nano-coating of boron nitride (BN) to stabilize solid electrolytes in lithium metal batteries. Their findings are outlined in a new study published by Joule.
Simon Billinge, a Professor of Materials Science and Engineering and Applied Physics and Applied Mathematics and a Scientist at Brookhaven National Laboratory, and APAM alumn, Dr. Chenyang Shi (Ph.D. 2015, Materials Science and Engineering), were recently featured in the following article by Mary Alexandra Agner. It was originally published as highlight on the Advanced Photon Source/Argonne National Laboratory website.
I. Cevdet Noyan, Professor of Materials Science and Engineering and of Earth and Environmental Engineering and former Chair of the APAM Department, has won the 2019 Hanawalt Award from the International Centre for Diffraction Data (ICDD). He was selected for this honor for his many contributions to X-ray diffraction methods and for the depth and breadth of knowledge in combining materials science and diffraction characterization.
Simon Billinge, who holds joint appointments in APAM & BNL, was featured in Chemistry World. Billinge’s group uses techniques to tackle real world problems, improving the properties of advanced materials by subtly altering their molecular structures. These might be high temperature superconductors, batteries or photovoltaic cells, or, increasingly, pharmaceuticals. Many of the “failed” compounds on drug companies’ shelves are potent & selective inhibitors of their molecular targets but are too insoluble to enter the bloodstream. Reformulating by reducing the particle size can sometimes increase the solubility of a ‘brick dust’-like compound by as much as a thousand times.